Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive ImpairmentJung Eun Park, Kun Ho Lee, Eun Hyun Seo et al.|Dementia and Geriatric Cognitive Disorders Extra|2019Cited by 35
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s diseaseJung Eun Park, Do Sung Lim, Yeong Hee Cho et al.|Biomarker Research|2021Cited by 19
High-throughput epitope profiling of antibodies in the plasma of Alzheimer’s disease patients using random peptide microarraysKyu-Young Sim, Sangheon Park, Kyu Yeong Choi et al.|Scientific Reports|2019Cited by 18
Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer’s Disease Spectrum with Amyloid PET ImagingHo Jae Lim, Kun Ho Lee, Jung Eun Park et al.|Journal of Alzheimer s Disease|2020Cited by 12
Alzheimer's disease risk associated with changes in Epstein-Barr virus nuclear antigen 1-specific epitope targeting antibody levelsKyu-Young Sim, Sung‐Gyoo Park, Jaekyeung An et al.|Journal of Infection and Public Health|2024Cited by 8